Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface
Takahiro Ohashi(Zenyaku Kogyo (Japan)), Keiko Fukushima(Zenyaku Kogyo (Japan))
Cited by 1
Related Papers
ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
|Cancer Research Communications|2026|0